We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current VYCO market cap is 2.33M. The company's latest EPS is USD -0.0118 and P/E is -5.93.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.48M | 1.14M | 1.39M | 1.22M | 1.46M |
| Operating Income | -725k | -727k | -436k | -307k | 41k |
| Net Income | -1.12M | -1.15M | -760k | -729k | -394k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.09M | 987k | 935k | 860k | 992k |
| Total Liabilities | 2.45M | 2.97M | 3.33M | 3.8M | 4.32M |
| Total Equity | -1.35M | -1.98M | -2.4M | -2.94M | -3.33M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 7k | -249k | 21k | -217k | 29k |
| Investing | -58k | -52k | -38k | -3k | -9k |
| Financing | 40k | 286k | 62k | 166k | N/A |
| Market Cap | 2.33M |
| Price to Earnings Ratio | -5.93 |
| Price to Sales Ratio | 1.6 |
| Price to Cash Ratio | 41.18 |
| Price to Book Ratio | -0.7 |
| Dividend Yield | - |
| Shares Outstanding | 33.37M |
| Average Volume (1 week) | 12.1k |
| Average Volume (1 Month) | 8.94k |
| 52 Week Change | 9.91% |
| 52 Week High | 0.1279 |
| 52 Week Low | 0.0325 |
| Spread (Intraday) | 0.02 (28.33%) |
| Company Name | Vycor Medical Inc (QB) |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.vycormedical.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
